المؤلفون: Zhou, Cathy, Yuan, Zilong, Ma, Weijie, Qi, Lihong, Mahavongtrakul, Angelique, Li, Ying, Li, Hong, Gong, Jay, Fan, Reggie R, Li, Jin, Molmen, Michael, Clark, Travis A, Pavlick, Dean, Frampton, Garrett M, Forcier, Brady, Moore, Elizabeth H, Shelton, David K, Cooke, Matthew, Ali, Siraj M, Miller, Vincent A, Gregg, Jeffrey P, Stephens, Philip J, Li, Tianhong

المصدر: Journal of Hematology & Oncology. 11(1)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Genetics, Human Genome, Genetic Testing, Clinical Research, Cancer, Good Health and Well Being, Adult, Aged, Circulating Tumor DNA, Female, Genomics, High-Throughput Nucleotide Sequencing, Humans, Male, Middle Aged, Positron Emission Tomography Computed Tomography, Retrospective Studies, Next-generation sequencing, Plasma, Cell-free DNA, Circulating tumor DNA, Genomic alterations, Maximum somatic allele frequency, Positron emission tomography (PET) scan, Maximum standardized uptake value, Cardiorespiratory Medicine and Haematology, Cardiovascular medicine and haematology, Oncology and carcinogenesis

الوصول الحر: https://escholarship.org/uc/item/33k195h4Test

المؤلفون: Zorisadday Gonzalez, Richard W. McCallum

المصدر: Gastrointestinal Disorders, Vol 2, Iss 2, Pp 58-70 (2020)

مصطلحات موضوعية: gastroparesis, brain imaging, functional magnetic resonance imaging (fMRI), positron emission tomography (PET) scan, central nervous system (CNS), Medicine, Diseases of the digestive system. Gastroenterology, RC799-869

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2624-5647/2/2/6Test; https://doaj.org/toc/2624-5647Test

الوصول الحر: https://doaj.org/article/175386f42a1345e98c6bffb1fd376129Test

المؤلفون: Richard W. McCallum, Zorisadday Gonzalez

المصدر: Gastrointestinal Disorders, Vol 2, Iss 6, Pp 58-70 (2020)

مصطلحات موضوعية: medicine.medical_specialty, gastroparesis, medicine.drug_class, Nausea, Central nervous system, lcsh:Medicine, brain imaging, Disease, central nervous system (CNS), 03 medical and health sciences, 0302 clinical medicine, Neuroimaging, medicine, Antiemetic, Gastroparesis, lcsh:RC799-869, Intensive care medicine, business.industry, lcsh:R, functional magnetic resonance imaging (fMRI), medicine.disease, Review article, positron emission tomography (PET) scan, medicine.anatomical_structure, Vomiting, lcsh:Diseases of the digestive system. Gastroenterology, 030211 gastroenterology & hepatology, medicine.symptom, business, 030217 neurology & neurosurgery

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bbf17dda46b0791af1116ad901d1072Test
https://doi.org/10.3390/gidisord2020006Test

المؤلفون: Travis A. Clark, Weijie Ma, Jay Gong, Zilong Yuan, David K. Shelton, Dean Pavlick, Brady Forcier, Elizabeth H Moore, Hong Li, Matthew Cooke, Vincent A. Miller, Michael Molmen, Reggie R. Fan, Garrett M. Frampton, Siraj M. Ali, Ying Li, Angelique Mahavongtrakul, Cathy Zhou, Jin Li, Tianhong Li, Lihong Qi, Jeffrey P. Gregg, Philip J. Stephens

المصدر: Journal of hematology & oncology, vol 11, iss 1
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-13 (2018)
Journal of Hematology & Oncology

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Cardiorespiratory Medicine and Haematology, Circulating Tumor DNA, Positron emission tomography (PET) scan, Cell-free DNA, Plasma, 0302 clinical medicine, Positron Emission Tomography Computed Tomography, Cancer, Whole blood, Hematology, Next-generation sequencing (NGS), High-Throughput Nucleotide Sequencing, lcsh:Diseases of the blood and blood-forming organs, Genomics, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Genomic alterations (GAs), 030220 oncology & carcinogenesis, Female, Fresh frozen plasma, Circulating tumor DNA (ctDNA), Adult, Maximum somatic allele frequency, medicine.medical_specialty, Concordance, Oncology and Carcinogenesis, lcsh:RC254-282, Maximum standardized uptake value, 03 medical and health sciences, Clinical Research, Cell-free DNA (cfDNA), Internal medicine, Maximum standardized uptake value (SUVmax), Genetics, medicine, Humans, In patient, Genetic Testing, Molecular Biology, Allele frequency, Retrospective Studies, Aged, Genomic alterations, lcsh:RC633-647.5, business.industry, Research, Human Genome, Maximum somatic allele frequency (MSAF), Retrospective cohort study, medicine.disease, Good Health and Well Being, 030104 developmental biology, Next-generation sequencing, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c76e30a4131443a806a8a1c458336a3Test
https://doi.org/10.1186/s13045-018-0671-8Test

المؤلفون: Wiebel, Jaime L., Banerjee, Mousumi, Muenz, Daniel G., Worden, Francis P., Haymart, Megan R.

مصطلحات موضوعية: radioiodine scan, surveillance imaging, differentiated thyroid cancer, positron emission tomography (PET) scan, neck ultrasound, Oncology and Hematology, Public Health, Health Sciences

وصف الملف: application/pdf

العلاقة: Wiebel, Jaime L.; Banerjee, Mousumi; Muenz, Daniel G.; Worden, Francis P.; Haymart, Megan R. (2015). "Trends in imaging after diagnosis of thyroid cancer." Cancer 121(9): 1387-1394.; https://hdl.handle.net/2027.42/111216Test; Cancer; Palaniswamy SS, Subramanyam P. Diagnostic utility of PETCT in thyroid malignancies: an update. Ann Nucl Med. 2013; 27: 681 ‐ 693.; Greene FP, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual. 6th ed. New York: Springer‐Verlag; 2002.; Percy C, Fritz A. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.; National Cancer Institute. SEER Stat Fact Sheets: Thyroid Cancer. seer.cancer.gov/statfacts/html/thyro.html. Accessed July 26, 2014.; Hu YY, Kwok AC, Jiang W, et al. High‐cost imaging in elderly patients with stage IV cancer. J Natl Cancer Inst. 2012; 104: 1164 ‐ 1172.; Witkowski ER, Smith JK, Ragulin‐Coyne E, Ng SC, Shah SA, Tseng JF. Is it worth looking? Abdominal imaging after pancreatic cancer resection: a national study. J Gastrointest Surg. 2012; 16: 121 ‐ 128.; Dinan MA, Curtis LH, Carpenter WR, et al. Variations in use of PET among Medicare beneficiaries with non‐small cell lung cancer, 1998‐2007. Radiology. 2013; 267: 807 ‐ 817.; Rueth NM, Xing Y, Chiang YJ, et al. Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage‐specific surveillance strategies. Ann Surg. 2014; 259: 1215 ‐ 1222.; Prasad SM, Gu X, Lipsitz SR, Nguyen PL, Hu JC. Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States. Cancer. 2012; 118: 1260 ‐ 1267.; Haber RS. Role of ultrasonography in the diagnosis and management of thyroid cancer. Endocr Pract. 2000; 6: 396 ‐ 400.; Mazzaferri EL, Kloos RT. Is diagnostic iodine‐131 scanning with recombinant human TSH useful in the follow‐up of differentiated thyroid cancer after thyroid ablation? J Clin Endocrinol Metab. 2002; 87: 1490 ‐ 1498.; Vera P, Kuhn‐Lansoy C, Edet‐Sanson A, et al. Does recombinant human thyrotropin‐stimulated positron emission tomography with [18F]fluoro‐2‐deoxy‐D‐glucose improve detection of recurrence of well‐differentiated thyroid carcinoma in patients with low serum thyroglobulin? Thyroid. 2010; 20: 15 ‐ 23.; Dennis K, Hay JH, Wilson DC. Effect of (18)F‐fluorodeoxyglucose positron emission tomography/computed tomography‐guided management of suspected recurrent papillary thyroid carcinoma: long‐term follow‐up with tumour marker responses. Clin Oncol (R Coll Radiol). 2012; 24: e168 ‐ e172.; Creach KM, Nussenbaum B, Siegel BA, Grigsby PW. Thyroid carcinoma uptake of 18F‐fluorodeoxyglucose in patients with elevated serum thyroglobulin and negative 131I scintigraphy. Am J Otolaryngol. 2013; 34: 51 ‐ 56.; Wang W, Larson SM, Fazzari M, et al. Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab. 2000; 85: 1107 ‐ 1113.; Centers for Medicare and Medicaid Services. National Coverage Determination (NCD) for PET Scans. cms.gov/medicare‐coverage‐database/details/ncd‐details.aspx?NCDId=211&ncdver=3&NCAId=104&NcaName=P ositron+Emission+Tomography+(FDG)+and+Other+Neuroimaging+Devices+for+Suspected+Dementia&IsPopup=y&bc=AAAAAAAAAEAAAA%3d%3d&. Accessed July 8, 2014.; Iyer NG, Morris LG, Tuttle RM, Shaha AR, Ganly I. Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Cancer. 2011; 117: 4439 ‐ 4446.; Lin HW, Bhattacharyya N. Survival impact of treatment options for papillary microcarcinoma of the thyroid. Laryngoscope. 2009; 119: 1983 ‐ 1987.; Goffredo P, Roman SA, Sosa JA. Have 2006 ATA practice guidelines affected the treatment of differentiated thyroid cancer in the United States? Thyroid. 2014; 24: 463 ‐ 471.; Butler Nattinger A, Schapira MM, Warren JL, Earle CC. Methodological issues in the use of administrative claims data to study surveillance after cancer treatment. Med Care. 2002; 40 ( suppl 8 ): IV ‐ 69‐IV‐74.; Warren JL, Harlan LC, Fahey A, et al. Utility of the SEER‐Medicare data to identify chemotherapy use. Med Care. 2002; 40 ( suppl 8 ): IV ‐ 55‐IV‐61.; Kowalczyk KJ, Harbin AC, Choueiri TK, et al. Use of surveillance imaging following treatment of small renal masses. J Urol. 2013; 190: 1680 ‐ 1685.; Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER‐Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002; 40 ( suppl 8 ): IV ‐ 3‐IV‐18.; Morris LG, Sikora AG, Tosteson TD, Davies L. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid. 2013; 23: 885 ‐ 891.; Smith‐Bindman R, Miglioretti DL, Johnson E, et al. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996‐2010. JAMA. 2012; 307: 2400 ‐ 2409.; Bhargavan M, Sunshine JH. Utilization of radiology services in the United States: levels and trends in modalities, regions, and populations. Radiology. 2005; 234: 824 ‐ 832.; Gimbel RW, Fontelo P, Stephens MB, et al. Radiation exposure and cost influence physician medical image decision making: a randomized controlled trial. Med Care. 2013; 51: 628 ‐ 632.; Hyder O, Dodson RM, Mayo SC, et al. Post‐treatment surveillance of patients with colorectal cancer with surgically treated liver metastases. Surgery. 2013; 154: 256 ‐ 265.; Hyder O, Dodson RM, Weiss M, et al. Trends and patterns of utilization in post‐treatment surveillance imaging among patients treated for hepatocellular carcinoma. J Gastrointest Surg. 2013; 17: 1774 ‐ 1783.; Vargas GM, Sheffield KM, Parmar AD, Han Y, Brown KM, Riall TS. Physician follow‐up and observation of guidelines in the post treatment surveillance of colorectal cancer. Surgery. 2013; 154: 244 ‐ 255.; Hahn EE, Hays RD, Kahn KL, Litwin MS, Ganz PA. Use of imaging and biomarker tests for posttreatment care of early‐stage breast cancer survivors. Cancer. 2013; 119: 4316 ‐ 4324.; Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014; 140: 317 ‐ 322.; National Cancer Institute. Cancer Trends Progress Report‐2011/2012 Update. progressreport.cancer.gov. Accessed July 15, 2014.; American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009; 19: 1167 ‐ 1214.; Cobin RH, Gharib H, Bergman DA, et al; Thyroid Carcinoma Task Force. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract. 2001; 7: 202 ‐ 220.; Pacini F, Castagna MG, Brilli L, Pentheroudakis G, ESMO Guidelines Working Group. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow‐up. Ann Oncol. 2012; 23 ( suppl 7 ): vii110 ‐ vii119.; Rosario PW, Furtado Mde S, Mineiro Filho AF, Lacerda RX, Calsolari MR. Value of diagnostic radioiodine whole‐body scanning after initial therapy in patients with differentiated thyroid cancer at intermediate and high risk for recurrence. Thyroid. 2012; 22: 1165 ‐ 1169.; Lal G, Fairchild T, Howe JR, Weigel RJ, Sugg SL, Menda Y. PET‐CT scans in recurrent or persistent differentiated thyroid cancer: is there added utility beyond conventional imaging? Surgery. 2010; 148: 1082 ‐ 1089; discussion 1089‐1090.; National Cancer Institute. Overview of the SEER Program. seer.cancer.gov/about/overview.html. Accessed July 7, 2014.

الإتاحة: https://doi.org/10.1002/cncr.29210Test
https://hdl.handle.net/2027.42/111216Test